 SANTA CLARA, Calif., July 15, 2021 GLOBE NEWSWIRE -- Shockwave Medical, Inc. Nasdaq: SWAV, a pioneer in the development and commercialization of Intravascular Lithotripsy IVL to treat complex calcified cardiovascular disease, today announced it will report financial results for the second quarter 2021 before market open on Monday, August 9, 2021. Company management will host a corresponding conference call beginning at 5:30 a.m. Pacific Time 8:30 a.m. Eastern Time. 